Latest Content

New Agent Can Improve BCG Response, Quality of Life in Bladder Cancer

September 18th 2021, 3:00pm

By Courtney Marabella


The novel drug N-803 boosted response to Bacille Calmette-Guérin therapy in patients with non-muscle invasive bladder cancer, a study showed.

How One Cancer Nurse Exhibits Compassion on a Daily Basis

September 18th 2021, 2:00pm

By Elisabeth Schlegel


During anxious times throughout treatment, one patient details how her oncology nurse helped her to relax at visits to her cancer center.

What Patients With Testicular Cancer Should Know About Fertility

September 17th 2021, 9:00pm

By Leah Lawrence


Despite a testicular cancer diagnosis, men have options when it comes to starting or growing their family.

A Cancer Survivor Unpacks the Impacts of Society’s Labels: 'Am I a Victim or a Survivor?'

September 17th 2021, 7:00pm

By Robin Zimmerman


A melanoma survivor and former caregiver analyzes the way society’s labels shape our behaviors and identities.

Lack of Smoking Data in Bladder, Kidney and Prostate Cancer Clinical Trials May Affect Patient Outcomes

September 17th 2021, 5:00pm

By Colleen Moretti


Clinical trials that are designed to ask patients with bladder, kidney and prostate cancer about their smoking status may help patients better understand what to expect from their treatment based on their smoking habits.

Jeff Bridges Announces Remission From Lymphoma, Cancer Survivor Becomes Runway Model and More

September 17th 2021, 3:00pm

By Jamie Cesanek


From Jeff Bridges achieving remission from cancer to a cancer survivor who became a runway model, here’s what’s happening in the cancer landscape this week.

Mantle Cell Lymphoma Treatment in the Era of COVID-19

September 17th 2021, 1:00pm

By Brielle Benyon


After determining an aggressive or non-aggressive treatment approach to mantle cell lymphoma, patients and clinicians must then discuss COVID-19 vaccine efficacy when determining a maintenance treatment strategy.

Survey for Caregivers of Relatives in Families With an Inherited Mutation Linked to Cancer

September 17th 2021, 11:45am


If you have an inherited mutation linked to cancer and/or cancer in your family and you have ever been a caregiver for a relative with cancer, FORCE would like to hear from you.

Medicare Eligibility May Be Associated With More Cancer Diagnoses

September 16th 2021, 9:00pm

By Antonia DePace


The eligible age of 65 years for Medicare may be discouraging patients from getting screenings and tests as they wait for more health coverage.

Experiencing Post Traumatic Stress After Cancer

September 16th 2021, 7:00pm

By William Ramshaw


A cancer survivor explains that similar to combat veterans who experience post-traumatic stress after war, cancer survivors live with the impacts of their journey even after being in remission.

Lesbian, Gay, Bisexual Cancer Survivors Experiencing More Challenges in Survivorship Than Heterosexuals

September 16th 2021, 5:00pm

By Colleen Moretti


Cancer survivors who identify as lesbian, gay or bisexual report experiencing significantly more challenges in their survivorship than their heterosexual peers, according to recent study results.

Reevaluating Treatment for Penile Cancer to Avoid Surgery

September 16th 2021, 3:00pm

By Darlene Dobkowski, MA


A first-of-its-kind trial underway in patients with penile cancer may lead to a more effective therapy sequence, potentially avoiding unnecessary surgery.

Fear of Dying From Cancer Shouldn't Stop You From Living

September 16th 2021, 1:00pm

By Dana Stewart


Through the emotions and anxiety of cancer, she realized she was not living her life to the fullest, and that it isn't over yet.

Carefully Choosing My Cancer Doctor

September 16th 2021, 11:45am


Doris Bowdoin researched to find the best doctor for her pancreatic cancer. Now she advocates for others through the Witches of St. Andrews.

FDA Approves Exkivity as First Oral Therapy for Lung Cancer Subset

September 15th 2021, 9:29pm

By Jamie Cesanek


The FDA’s approval of Exkivity marks the first approved oral therapy for this subgroup of patients with non-small cell lung cancer.